跳至主要内容
临床试验/NCT00922181
NCT00922181已完成不适用

Single-probe Microwave Ablation of Metastatic Liver Cancer is Highly Variable and Irreproducible

University Hospital, Gasthuisberg2 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2008年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
19
试验地点
2
主要终点
Variability of ablation diameters

研究概览

简要总结

Microwave ablation (MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate the variability and reproducibility of single-probe MWA versus radiofrequency ablation (RFA) of metastatic liver tumours smaller than 3 cm in patients without underlying liver disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Unresectable metastatic liver cancer
  • No invasion of major biliary structures
  • No invasion of major vascular structures
  • ASA score < 4
  • WHO score 0-1
  • Pre-operative chemotherapy is allowed

排除标准

  • Resectable liver metastases
  • Life expectancy less than 3 months
  • Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials
  • Coagulopathy with platelet count less than 50000
  • Active infectious disease
  • Age below 18 years
  • Pregnancy of breastfeeding

结局指标

主要结局

Variability of ablation diameters

时间窗: within the first 7 days and 3 months after surgery

次要结局

未报告次要终点

研究者

发起方
University Hospital, Gasthuisberg
申办方类型
Other

研究点 (2)

Loading locations...

相似试验